Results 161 to 170 of about 24,516,016 (295)
Brain targeting and trafficking of extracellular vesicles in central nervous system diseases: a therapeutic roadmap. [PDF]
Nanomedicine (Lond)Baker B +11 more
europepmc +1 more source
, 1999 This volume is the third and final part of the planned coverage of the neurochemical circuitry of the primate central nervous system. The five chapters included in this volume complement and integrate magnificently with the two prior volumes. Included in
Bloom, Floyd E.edt +1 more
core
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Gliomas have undergone a profound redefinition over the past decade, transitioning from morphology‐based entities to biologically coherent diseases defined by molecular alterations. The 2021 WHO Classification of Tumors of the Central Nervous System and its 2022 update formalize this shift, establishing integrated diagnosis as the global ...
Maria Guarnaccia, Sebastiano Cavallaro
wiley +1 more source
Gold Nanoparticles in Central Nervous System Diseases: Recent Progress, Challenges, and Therapeutic Opportunities. [PDF]
Nano LettHan S, Bouchrara S, Al-Jamal KT.
europepmc +1 more source
Endothelial Cell Proteins as Biomarkers in Susac Syndrome
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Susac syndrome (SS) is a rare CD8+ T cell–mediated microangiopathy affecting the brain, retina, and auditory labyrinth. Endothelial injury is thought to be a central mechanism; however, no circulating disease biomarkers are known. We performed targeted proteomic profiling to identify circulating endothelial‐associated proteins as ...
Rohit Benjamin +11 more
wiley +1 more source
Neutrophil Extracellular Traps in Central Nervous System Diseases. [PDF]
Curr NeuropharmacolZhu J, Zhu H, Hou W, Liu JY.
europepmc +1 more source
Diagnostic value of NMO-IgG in demyelinating diseases of central nervous system
, 2016 The aquaporin 4 (AQP4) plays an important role in the maintenance of transmembrane water transfer, blood-brain barrier (BBB) integrity and homeostasis of central nervous system, and its highly specific autoantibody NMO-IgG has been used as a specific ...
You-dong WEI, Xiao-min XU
core
Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui +10 more
wiley +1 more source
Enhancing plasticity to treat depression and other central nervous system diseases using event-driven pharmacology. [PDF]
J PsychopharmacolGould TD, Mathew SJ, Fava M, Shekhar A.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu +10 more
wiley +1 more source